Cargando…

Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma

Hepatocellular-cholangiocarcinoma (H-ChC) is a rare subtype of liver cancer with clinicopathological features of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). To date, molecular mechanisms underlying the co-existence of HCC and iCCA components in a single tumor rema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Anqiang, Wu, Liangcai, Lin, Jianzhen, Han, Longzhe, Bian, Jin, Wu, Yan, Robson, Simon C., Xue, Lai, Ge, Yunxia, Sang, Xinting, Wang, Wenze, Zhao, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832792/ https://www.ncbi.nlm.nih.gov/pubmed/29497050 http://dx.doi.org/10.1038/s41467-018-03276-y

Ejemplares similares

Combination treatment including targeted therapy for advanced hepatocellular carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2016)

Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma
por: Xiong, Jianping, et al.
Publicado: (2017)

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017)

Patterns of Whole Exome Sequencing in Resected Cholangiocarcinoma
por: Thornblade, Lucas W., et al.
Publicado: (2021)

Brain metastases from hepatocellular carcinoma: recent advances and future avenues
por: Wang, Shanshan, et al.
Publicado: (2017)

Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing
por: Zheng, Yongchang, et al.
Publicado: (2017)

Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression
por: Lin, Jianzhen, et al.
Publicado: (2018)

Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct
por: Wan, Xueshuai, et al.
Publicado: (2017)

Apatinib as non-first-line treatment in patients with Intrahepatic Cholangiocarcinoma
por: Mao, Jinzhu, et al.
Publicado: (2021)

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy
por: Long, Junyu, et al.
Publicado: (2017)

Tea consumption and the risk of biliary tract cancer: a systematic review and dose–response meta-analysis of observational studies
por: Xiong, Jianping, et al.
Publicado: (2017)

The fusion landscape of hepatocellular carcinoma
por: Zhu, Chengpei, et al.
Publicado: (2019)

Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma
por: Zhang, Haohai, et al.
Publicado: (2015)

Coffee and cancer risk: A meta-analysis of prospective observational studies
por: Wang, Anqiang, et al.
Publicado: (2016)

dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers
por: Yang, Zhen, et al.
Publicado: (2017)

A resected case of hepato-pancreaticoduodenectomy for widely extended cholangiocarcinoma undergoing previous intra-abdominal poly-surgery
por: Nanashima, Atsushi, et al.
Publicado: (2018)

MALDI Imaging, a Powerful Multiplex Approach to Decipher Intratumoral Heterogeneity: Combined Hepato-Cholangiocarcinomas as Proof of Concept
por: Gigante, Elia, et al.
Publicado: (2023)

Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma
por: Huang, Hanchun, et al.
Publicado: (2019)

Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma
por: Jin, Bao, et al.
Publicado: (2023)

Expression of endoplasmic reticulum oxidoreductase 1-α in cholangiocarcinoma tissues and its effects on the proliferation and migration of cholangiocarcinoma cells
por: Yan, Wendi, et al.
Publicado: (2019)

Hepato-biliopancreatic surgery in the elderly
por: Pellegrino, V, et al.
Publicado: (2010)

Hepato-Intestinal Toxæmia.—I
Publicado: (1909)

Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
por: Long, Junyu, et al.
Publicado: (2021)

Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
por: Bian, Xinyi, et al.
Publicado: (2023)

Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma
por: Li, Hanyu, et al.
Publicado: (2019)

Elastography for hepato-biliary-pancreatic surgery
por: Inoue, Yosuke, et al.
Publicado: (2013)

The Treatment of Hepato-Intestinal Toxæmia.—II
Publicado: (1909)

Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model
por: Li, Changcan, et al.
Publicado: (2022)

Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2017)

Experimental Study of Somatic Variants of Osteosarcoma by Whole-Exome Sequencing
por: Hou, Jingyu, et al.
Publicado: (2020)

Whole-exome sequencing study of hypospadias
por: Chen, Zhongzhong, et al.
Publicado: (2023)

Whole exome sequencing in the rat
por: Foley, Julie F., et al.
Publicado: (2018)

Metabolomics and Whole-Exome Sequencing in Patients with Differential Sensitivity to Sevoflurane: A Protocol for a Prospective Observational Trial
por: Wei, Yiyong, et al.
Publicado: (2021)

Syndromic diarrhea/Tricho-hepato-enteric syndrome
por: Fabre, Alexandre, et al.
Publicado: (2013)

Hepato-biliary stem cells: facts and fancies
por: Theise, Neil D
Publicado: (2014)

Hepato‐preferential insulins: Is this the end, or the end of the beginning?
por: Russell‐Jones, D. L.
Publicado: (2016)

Recent advances in hepato‐biliary‐pancreatic surgery
por: Horiguchi, Akihiko
Publicado: (2020)

Identification of potential genetic causal variants for rheumatoid arthritis by whole-exome sequencing
por: Li, Ying, et al.
Publicado: (2017)

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
por: Long, Junyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2jpvv277hgc7khnh94daonjm1u